Skip to main content

Table 2 The prognostic value of plasma exosome-derived Cx43 levels in melanoma patients

From: Plasma exosome-derived connexin43 as a promising biomarker for melanoma patients

Variable

prognostic value (n = 112)

5-year DFS

 

AUROC

0.78(95% CI: 0.70–0.86)

Cutoff value (95%CI)

0.69

Sensitivity, %

81.55(95% CI: 72.70–88.50)

Specificity, %

77.78(95% CI: 40.00-97.20)

Positive predictive value, %

97.70(95% CI: 91.90–99.70)

Negative predictive value, %

26.90(95% CI: 11.60–47.80)

Positive likelihood ratio

3.67(95% CI: 1.10–12.50)

Negative likelihood ratio

0.24(95% CI: 0.10–0.40)

5-year OS

 

AUROC

0.77(95% CI: 0.68–0.84)

Cutoff value (95%CI)

0.67

Sensitivity, %

65.98(95% CI: 55.70–75.30)

Specificity, %

80.00(95% CI: 51.90–95.70)

Positive predictive value, %

95.50(95% CI: 87.50–99.10)

Negative predictive value, %

26.70(95% CI: 14.60–41.90)

Positive likelihood ratio

3.30(95% CI: 1.20–9.20)

Negative likelihood ratio

0.43(95% CI: 0.30–0.60)